Search Results - "WAGNER, LASZLO"

Refine Results
  1. 1

    SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes by Hodrea, Judit, Saeed, Adar, Molnar, Agnes, Fintha, Attila, Barczi, Adrienn, Wagner, Laszlo J, Szabo, Attila J, Fekete, Andrea, Balogh, Dora B

    Published in PloS one (17-02-2022)
    “…Cardiovascular disease (CVD) is two to five times more prevalent in diabetic patients and is the leading cause of death. Therefore, identification of novel…”
    Get full text
    Journal Article
  2. 2

    The Sigma-1 Receptor Is a Novel Target for Improving Cold Preservation in Rodent Kidney Transplants by Hosszu, Adam, Toth, Akos R, Lakat, Tamas, Stepanova, Ganna, Antal, Zsuzsanna, Wagner, Laszlo J, Szabo, Attila J, Fekete, Andrea

    “…Kidney transplantation is the preferred treatment for patients with end-stage kidney disease. Maintaining organ viability between donation and transplantation,…”
    Get full text
    Journal Article
  3. 3

    RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition by Koszegi, Sandor, Molnar, Agnes, Lenart, Lilla, Hodrea, Judit, Balogh, Dora Bianka, Lakat, Tamas, Szkibinszkij, Edgar, Hosszu, Adam, Sparding, Nadja, Genovese, Federica, Wagner, Laszlo, Vannay, Adam, Szabo, Attila J, Fekete, Andrea

    Published in The Journal of physiology (01-01-2019)
    “…Key points Increased activation of the renin‐angiotensin‐aldosterone system (RAAS) and elevated growth factor production are of crucial importance in the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model by Balogh, Dora B, Molnar, Agnes, Degi, Arianna, Toth, Akos, Lenart, Lilla, Saeed, Adar, Barczi, Adrienn, Szabo, Attila J, Wagner, Laszlo J, Reusz, Gyorgy, Fekete, Andrea

    “…Diabetic cardiovascular complications are associated with up to 50% mortality, and current therapies are not effective enough. Renin-angiotensin-aldosterone…”
    Get full text
    Journal Article
  6. 6

    An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis by Balogh, Dora Bianka, Wagner, Laszlo Jozsef, Fekete, Andrea

    “…Metabolic diseases, particularly diabetes mellitus (DM), are significant global public health concerns. Despite the widespread use of standard-of-care…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Aldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats by Banki, Nora F, Ver, Agota, Wagner, Laszlo J, Vannay, Adam, Degrell, Peter, Prokai, Agnes, Gellai, Renata, Lenart, Lilla, Szakal, Dorottya-Nagy, Kenesei, Eva, Rosta, Klara, Reusz, Gyorgy, Szabo, Attila J, Tulassay, Tivadar, Baylis, Chris, Fekete, Andrea

    Published in PloS one (28-06-2012)
    “…Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are the standard clinical therapy of diabetic nephropathy (DN),…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system by Erdely, Aaron, Greenfeld, Ziv, Wagner, Laszlo, Baylis, Chris

    Published in Kidney international (01-03-2003)
    “…Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system. Male gender confers enhanced susceptibility to development of age-dependent…”
    Get full text
    Journal Article
  11. 11

    Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney – another reason for diabetic nephropathy? by Fekete, Andrea, Rosta, Klara, Wagner, Laszlo, Prokai, Agnes, Degrell, Peter, Ruzicska, Eva, Vegh, Edit, Toth, Miklos, Ronai, Katalin, Rusai, Krisztina, Somogyi, Aniko, Tulassay, Tivadar, Szabo, Attila J, Ver, Agota

    Published in The Journal of physiology (15-11-2008)
    “…Angiotensin II (ANGII) plays a central role in the enhanced sodium reabsorption in early type 1 diabetes in man and in streptozotocin-induced (STZ) diabetic…”
    Get full text
    Journal Article
  12. 12

    Renal neuronal nitric oxide synthase protein expression as a marker of renal injury by Szabo, Attila J., Wagner, Laszlo, Erdely, Aaron, Lau, Kim, Baylis, Chris

    Published in Kidney international (01-11-2003)
    “…Renal neuronal nitric oxide synthase protein expression as a marker of renal injury. Animal studies suggest that nitric oxide deficiency occurs in the remnant…”
    Get full text
    Journal Article
  13. 13

    Oncological Screening of Kidney Transplant Patients: The Role of Ultrasound Examination by Kiss, Gergely, Korda, Dávid, Szabó, Gergő, Juhász, Réka, Wagner, László, Máthé, Zoltán, Doros, Attila, Végső, Gyula

    Published in Transplantation proceedings (01-05-2019)
    “…Immunosuppressive therapy used after organ transplantation represents a considerable oncological risk. Abdominal ultrasound examinations play an essential role…”
    Get full text
    Journal Article
  14. 14

    Case report: COVID-19 infection in a pregnant 33-year-old kidney transplant recipient by Supák, Dorina, Mészáros, Balázs, Nagy, Márta, Gáspár, Dániel, Wagner, László J., Kukor, Zoltán, Valent, Sándor

    Published in Frontiers in medicine (30-08-2022)
    “…Patients facing severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infections with comorbidities, especially patients whose immune system is weakened…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosis by Kerti, Andrea, Csohány, Rózsa, Wagner, László, Jávorszky, Eszter, Maka, Erika, Tory, Kálmán

    Published in Pediatric nephrology (Berlin, West) (01-10-2013)
    “…Background The pathogenicity of the NPHS2 homozygous p.R229Q variant in steroid-resistant nephrotic syndrome (SRNS) is doubtful. While it has been reported in…”
    Get full text
    Journal Article
  19. 19

    Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective Analysis by Farkas, Katalin, Varga, Marina, Dinnyes, Izabella, Rem, Lili, Telkes, Gabor, Wagner, Laszlo, Remport, Adam, Piros, Laszlo, Szijarto, Attila, Huszty, Gergely

    Published in Transplantation proceedings (01-01-2024)
    “…Prophylactic administration of valganciclovir (VG) is an accepted method for the prevention of cytomegalovirus (CMV) infection after kidney transplantation…”
    Get full text
    Journal Article
  20. 20